An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05367960 |
|
Recruitment Status :
Enrolling by invitation
First Posted : May 10, 2022
Last Update Posted : January 25, 2024
|
Sponsor:
Tetra Discovery Partners
Information provided by (Responsible Party):
Tetra Discovery Partners
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | February 2024 |
| Estimated Study Completion Date : | December 2025 |